查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1806639

全球細胞培養市場（按產品類型、細胞類型、技術、應用和最終用戶分類）預測（2025-2030 年）

Cell Culture Market by Product Type, Cell Type, Technique, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年細胞培養市場價值將達268.9億美元，2025年將成長至307.7億美元，複合年成長率為14.58%，到2030年將達到608.9億美元。

主要市場統計數據
基準年2024年 268.9億美元
預計2025年 307.7億美元
預測年份 2030 608.9億美元
複合年成長率（%） 14.58%

細胞培養技術支持廣泛的創新領域，推動藥物研發、再生醫學和生物製造領域的關鍵進步。從經典培養基配方的改進到專用無血清培養基的出現，實驗室科學家和製程工程師都利用不斷發展的通訊協定，在細胞株開發和生物製程最佳化方面開闢了新的可能性。此外，從一次性生物反應器系統到自動化低溫保存解決方案等先進設備的融合，正在進一步加速研究和商業生產環境中的通量、可重複性和可擴展性。

在此背景下，在科學突破、法律規範轉變和全球供應鏈重組的推動下，細胞培養生態系統正經歷變革。隨著3D和灌注等新型培養技術的日益普及，相關人員面臨著在技術創新與營運韌性之間取得平衡的需求。因此，對於尋求駕馭複雜環境並利用新成長載體的決策者而言，深入了解產品類型、細胞株類別、應用領域和最終用戶特徵的細分至關重要。本執行摘要旨在提供對重新定義細胞培養的力量的統一視角，並重點介紹將指南策略選擇和未來市場進入的關鍵轉變，從而奠定基礎。

引領前所未有的技術突破和監管變革時代，重新定義生物製藥和學術界的細胞培養過程

細胞培養領域正經歷前所未有的變革，技術突破和不斷變化的監管環境重新定義了實驗室的運作方式。近年來，從手動的桌上型工作流程到自動化、高通量平台的轉變顯著提高了實驗的可重複性和操作效率。同時，監管機構正在推動採用無血清和化學成分明確的培養基，以強調嚴格的品管，降低差異性，並確保符合良好生產規範 (GMP)。

評估近期關稅調整對美國細胞培養供應鏈和商業支出的深遠影響

美國近期對實驗室耗材和設備進口關稅的調整，為細胞培養運作帶來了新的複雜性。從專用培養基成分到精密設計的生物反應器系統等關鍵投入品的關稅不斷上漲，給採購成本帶來了上行壓力，迫使企業重新評估籌資策略。因此，供應鏈經理正在透過多元化供應商組合，並與國內製造商和區域分銷商建立二級夥伴關係來應對，以降低貿易政策波動對其造成的影響。

按產品類型、細胞類型、技術、應用和最終用戶揭示主要細胞培養市場的細分洞察

對細胞培養細分的細緻理解，為資源配置和策略規劃提供了至關重要的清晰度。在產品類型領域中，耗材和設備各自扮演著獨特而又相互依存的角色。在耗材方面，培養基配方涵蓋經典的鹽和基礎培養基、無血清培養基以及針對特定方案客製化的特殊混合物；而試劑類別則涵蓋抗菌劑、附著因子和基質蛋白。同時，血清來源範圍從動物到人，既反映了倫理考量，也反映了性能規範。在設備方面，其範圍從可擴展的生物反應器和離心平台，到先進的低溫保存設備和受控環境培養箱。

揭示細胞培養需求成長的區域細微差別，受關鍵地理區域的研究重點和生物製造能力的影響

區域動態對細胞培養的採用和創新軌跡有重大影響。在美洲，生物製藥研發的強勁投入以及成熟的受託製造廠商網路，支撐了對先進培養基系統、高通量篩檢平台和模組化一次性生物反應器的持續需求。此外，支持基因和細胞治療的舉措正在促進學術中心與商業營業單位之間的合作，從而形成一個既重視基礎研究又重視轉化應用的生態系統。

分析市場參與企業及其塑造細胞培養領域創新和競爭定位的策略要務

細胞培養領域的主要參與企業正在推行互補策略，以鞏固各自的地位並滿足最終用戶的多方面需求。一些供應商優先考慮垂直整合，簡化培養基原料成分從合成到填充和包裝的流程，確保可追溯性和一致的品質。另一些供應商則專注於策略聯盟，與專業技術開發人員合作，共同開發下一代無血清配方和針對連續加工進行最佳化的模組化設備架構。

將市場情報轉化為有針對性的可操作策略，旨在增強細胞培養營運彈性並推動永續成長

產業領導者可以透過採取多管齊下的方法，在創新與營運韌性之間取得平衡，從而充分利用新的洞察。首先，實現供應鏈多元化，涵蓋全球和區域供應商，可以減輕關稅波動和物流中斷的影響。其次，投資模組化自動化平台和數位化流程分析，可以加速方法開發，降低人工錯誤率，並實現關鍵發酵參數的即時監控。

為確保業界考察而採用的嚴謹調查方法和分析框架的詳細資訊

該分析基於嚴謹的調查方法，結合了原始訪談、二手資料檢驗和先進的分析框架。與高階主管、製程工程師和應用科學家進行了一系列深入討論，獲得了關於不斷變化的客戶需求、技術採用障礙和策略重點的第一手觀點。隨後，這些定性資訊與已發表的科學文獻、監管文件和公司揭露資訊進行了交叉核對，以全面涵蓋市場動態。

總結關鍵見解和策略技巧，幫助相關人員了解趨勢並利用細胞培養領域的商業機會

先進培養基配方、自動化設備和數據驅動工作流程的整合標誌著細胞培養領域的關鍵曲折點。關鍵亮點包括：日益成長的供應鏈敏捷性需求，以適應不斷變化的關稅；市場細分的戰略價值，以根據用戶需求客製化產品；以及隨著生物製造能力的全球擴張，區域差異化的重要性。在競爭格局中，既有綜合性生命科學公司，也有專注於利基市場的公司，它們在研發、夥伴關係位解決方案方面投入大量資金。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 整合人工智慧演算法，增強細胞培養監測與分析
  • 採用一次性生物反應器系統實現高效可擴展的哺乳動物細胞培養製造
  • 開發無血清、化學成分明確的培養基，以提高細胞培養的可重複性
  • 擴展3D支架技術，建構更生理相關性的細胞模型
  • 實現微流體器官晶片平台在細胞培養應用中模擬人體組織
  • 應用 CRISPR 基因編輯最佳化細胞株係以提高生產力和穩定性
  • 透過機器人技術和數位連接的整合來推進自動化細胞培養工作流程
  • 轉向永續和生物分解性的消耗品，以減少對環境的影響
  • 生物分解性和永續的耗材減少了大規模細胞培養作業對環境的影響
  • 培養整合即時代謝通量分析儀最佳化營養餵食策略

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章細胞培養市場（依產品類型）

  • 耗材
    • 培養基
      • 標準培養基和鹽
      • 無血清培養基
      • 專用培養基
    • 試劑
      • 抗生素/抗真菌藥物
      • 黏附和基質因素
    • 血清
      • 牛
      • 人血清
  • 裝置
    • 生物反應器
    • 離心機
    • 低溫保存系統
    • 培養箱

第9章 細胞培養市場（依細胞類型）

  • 昆蟲細胞
  • 哺乳動物細胞
  • 微生物細胞
  • 植物細胞
  • 幹細胞

第 10 章 細胞培養市場：依技術

  • QR 圖文化
  • 3D文化
  • 灌注培養
  • 懸浮培養

第 11 章細胞培養市場：依應用

  • 生物製藥製造
    • 單株抗體生產
    • 疫苗生產
  • 細胞銀行和儲存
    • 冷凍保存
    • 儲存服務
  • 臨床診斷
    • 免疫診斷
    • 分子診斷
  • 研究與開發
    • 藥物研發
    • 基因工程
    • 毒理學

第 12 章 細胞培養市場（依最終使用者）

  • 學術和研究機構
  • 生技公司
  • CRO
  • 醫院和診斷實驗室
  • 製藥公司

第 13 章：美洲細胞培養市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 14 章：歐洲、中東和非洲的細胞培養市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

第15章：亞太細胞培養市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • CellGenix GmbH
    • Corning Incorporated
    • Danaher Corporation
    • Emulate, Inc.
    • Eppendorf AG
    • Fujifilm Holdings Corporation
    • Hi-Media Laboratories
    • InSphero AG
    • Invivogen
    • Lonza Group
    • Merck & Co., Inc.
    • Miltenyi Biotec
    • PromoCell GmbH
    • Sartorius AG
    • Synthecon, Incorporated
    • Thermo Fisher Scientific Inc.
    • VWR International, LLC by Avantor, Inc.
    • Adolf Kuhner AG
    • Advancion Corporation
    • BioSpherix Ltd.
    • Becton, Dickinson and Company
    • Getinge AB
    • Agilent Technologies, Inc.
    • Bio-Techne Corporation
    • STEMCELL Technologies Canada Inc.
    • Solida Biotech GmBH
    • Caisson Labs Inc.
    • PAN-Biotech GmbH

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-034230D3E63B

The Cell Culture Market was valued at USD 26.89 billion in 2024 and is projected to grow to USD 30.77 billion in 2025, with a CAGR of 14.58%, reaching USD 60.89 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 26.89 billion
Estimated Year [2025] USD 30.77 billion
Forecast Year [2030] USD 60.89 billion
CAGR (%) 14.58%

Cell culture technologies underpin an expansive landscape of innovation, driving critical advances in drug discovery, regenerative medicine, and biomanufacturing. From the refinement of classical media formulations to the emergence of specialty serum-free media, laboratory scientists and process engineers alike have harnessed evolving protocols to unlock new possibilities in cell line development and bioprocess optimization. Moreover, the convergence of sophisticated instrumentation-ranging from single-use bioreactor systems to automated cryostorage solutions-has further accelerated throughput, reproducibility, and scalability across both research and commercial production environments.

Against this backdrop, the cell culture ecosystem is encountering transformative dynamics fueled by converging scientific breakthroughs, shifting regulatory frameworks, and global supply chain realignments. As novel culture techniques such as 3D and perfusion methodologies gain traction, stakeholders face the imperative to balance innovation with operational resilience. Consequently, a nuanced understanding of segmentation across product types, cell line categories, application domains, and end-user profiles is essential for decision makers seeking to navigate complexity and harness emerging growth vectors. This executive summary sets the stage by offering an integrated view of the forces redefining cell culture, spotlighting key shifts that will inform strategic choices and guide market engagement moving forward.

Navigating a Period of Unprecedented Technological Breakthroughs and Regulatory Evolution That Is Redefining Cell Culture Processes Across Biopharma and Academia

The cell culture landscape is in the midst of unprecedented evolution, propelled by technological breakthroughs and shifting regulatory mandates that are redefining how laboratories operate. In recent years, the transition from manual, bench-scale workflows to automated, high-throughput platforms has dramatically increased experimental reproducibility and operational efficiency. At the same time, regulatory authorities have emphasized stringent quality controls, driving the adoption of serum-free and chemically defined media to mitigate variability and ensure compliance with Good Manufacturing Practices.

Furthermore, continuous processing approaches-enabled by perfusion and suspension culture techniques-have challenged traditional batch paradigms, offering the potential for sustained productivity and reduced facility footprints. This technological maturation is complemented by the integration of digital monitoring tools, allowing real-time feedback on critical process parameters and supporting predictive analytics. As a result, organizations are increasingly investing in data-driven workflows to detect deviations early and optimize resource utilization.

Consequently, the interplay between innovation in cell culture methodologies and evolving regulatory expectations is shaping strategic priorities across academia, biotechnology companies, and contract research organizations. Stakeholders must now navigate a dual imperative: fostering creative experimentation while maintaining rigorous standards. The next sections of this summary will delve into how these transformative shifts translate into tangible impacts on supply chains, segmentation strategies, and competitive positioning within the cell culture domain.

Assessing the Far-Reaching Consequences of Recent Tariff Adjustments on Cell Culture Supply Chains and Operational Expenditures Across the United States

The recent adjustment of import duties on laboratory consumables and instrumentation has introduced a new layer of complexity to cell culture operations within the United States. Increased tariffs on key inputs-ranging from specialized media components to precision-engineered bioreactor systems-have exerted upward pressure on procurement costs and forced organizations to reevaluate sourcing strategies. In turn, supply chain managers have responded by seeking to diversify vendor portfolios, establishing secondary partnerships with domestic manufacturers and regional distributors to mitigate exposure to fluctuating trade policies.

Consequently, many research institutions and biomanufacturing facilities have adopted inventory optimization techniques, balancing just-in-time ordering with safety stock buffers to absorb potential disruptions. At the same time, negotiations around long-term contract pricing have become more sophisticated, incorporating clauses that address duty changes and currency variations. These strategic shifts have improved operational resilience, but not without requiring incremental investment in supply chain analytics and risk management capabilities.

Moreover, the tariff landscape has prompted end users to interrogate total cost of ownership more rigorously, factoring in logistics, storage, and customs handling alongside unit prices. As organizations seek to preserve research timelines and production schedules, they are increasingly experimenting with alternative media formulations and generic reagent suppliers. Looking ahead, stakeholders will need to maintain agility, leveraging predictive scenario modeling and collaborative supplier relationships to absorb further policy fluctuations without compromising scientific integrity or project deadlines.

Dissecting Critical Cell Culture Market Segmentation Insights Driven by Product, Cell Type, Technique, Application, and End User Dynamics Unveiled

A nuanced understanding of cell culture segmentation provides indispensable clarity for resource allocation and strategic planning. In the realm of product type, consumables and instruments each play distinct but interdependent roles. Within consumables, media formulations divide into classical salts and base media, serum-free variants, and specialty blends tailored for niche protocols, while reagent categories span antimicrobials, attachment factors, and matrix proteins. Meanwhile, serum offerings range from animal-derived sera to human-sourced alternatives, reflecting both ethical considerations and performance specifications. On the instruments side, the spectrum extends from scalable bioreactors and centrifugation platforms to advanced cryostorage units and environmental control incubators.

Turning to cell type, the field encompasses a diverse array of host systems. Mammalian cell lines remain central to biologics production, yet microbial systems offer rapid growth for enzyme and protein research. In parallel, insect and plant cells are leveraged for vaccine and recombinant protein expression, while stem cell models drive breakthroughs in regenerative therapies and disease modeling. Each host introduces unique culture requirements and analytical needs.

Technique-based differentiation highlights the rising prominence of three-dimensional scaffold systems and perfusion setups, complementing established two-dimensional and suspension culture workflows. These methodological choices directly influence media composition, hardware demands, and quality control parameters. Application segmentation further refines priorities: biopharmaceutical manufacturing operations prioritize monoclonal antibody and vaccine workflows, cell banking services emphasize cryopreservation protocols, diagnostic laboratories focus on immuno- and molecular assays, and academic R&D centers pursue drug discovery, genetic engineering, and toxicity testing.

Finally, end-user categories reveal how organizational objectives shape purchasing patterns. Academic institutions drive fundamental research but often have constrained budgets, biotechnology innovators seek agile solutions to accelerate product pipelines, contract research organizations emphasize turnkey service compatibility, diagnostic labs prioritize throughput and reproducibility, and pharmaceutical companies demand scalable processes for commercialization. Together, these segmentation insights illuminate pathways for targeted product development, customized solutions, and differentiated service offerings.

Uncovering Regional Nuances in Cell Culture Demand Growth Influenced by Research Priorities and Biomanufacturing Capabilities Across Key Geographic Zones

Regional dynamics exert a profound influence over the trajectory of cell culture adoption and innovation. In the Americas, robust investment in biopharmaceutical R&D, combined with a mature network of contract development and manufacturing organizations, underscores sustained demand for advanced media systems, high-throughput screening platforms, and modular single-use bioreactors. Furthermore, initiatives supporting gene and cell therapies have catalyzed collaborations between academic centers and commercial entities, fostering an ecosystem that values both foundational research and translational applications.

Across Europe, the Middle East & Africa, regulatory harmonization efforts have streamlined approval pathways, particularly for cell-based medicinal products. This environment has incentivized technology providers to develop compliant, fully characterized raw materials and instrumentation capable of meeting stringent quality standards. In parallel, growth in personalized medicine and autologous cell therapy has spurred demand for point-of-care incubation systems and closed-loop processing units. Collaborative frameworks between government bodies and industry consortia continue to shape infrastructure investment, emphasizing regional self-sufficiency in critical reagent manufacturing.

In Asia-Pacific, dynamic policy support for biotech innovation and cost-competitive manufacturing credentials have elevated the region's status as a global cell culture hub. Emerging players are investing heavily in specialized media development, local reagent production, and scalable bioreactor installations. Simultaneously, academic and clinical research organizations are expanding capabilities in organoid models and high-content screening. As a result, market participants must navigate a landscape defined by rapid capacity expansion, government incentives for domestic innovation, and a growing emphasis on affordable solutions tailored to local research priorities.

Profiling Leading Market Participants and Their Strategic Imperatives Shaping Innovation and Competitive Positioning in the Cell Culture Sector

Leading participants in the cell culture arena are pursuing complementary strategies to fortify their positions and address the multifaceted needs of end users. Some providers have prioritized vertical integration, streamlining the transition from raw media component synthesis through fill-finish and packaging, thereby ensuring traceability and consistent quality. Others have focused on strategic alliances, partnering with specialized technology developers to co-create next-generation serum-free formulations and modular instrumentation architectures optimized for continuous processing.

A subset of competitors is forging collaborations with contract research organizations and academic institutions, embedding expert applications support teams to accelerate customer adoption of advanced culture workflows. Meanwhile, established life sciences conglomerates are leveraging global distribution networks to expand reach into emerging markets, often coupling local regulatory expertise with centralized quality assurance capabilities. At the same time, nimble niche suppliers are differentiating through highly customized solutions, from tailor-made reagent kits to turnkey automation platforms, catering to unique process requirements.

Across the board, R&D investment remains a unifying theme, with companies allocating resources to digitalization initiatives, advanced analytics integration, and sustainable manufacturing practices. Whether through the launch of cloud-enabled process monitoring tools or the introduction of biodegradable single-use components, these strategic imperatives underscore a collective commitment to driving both performance and environmental responsibility in cell culture operations.

Translating Market Intelligence into Targeted Actionable Strategies Designed to Enhance Operational Resilience and Drive Sustainable Growth in Cell Culture

Industry leaders can harness emerging insights by adopting a multi-pronged approach that balances innovation with operational resilience. First, diversifying supply chains to include both global and regional suppliers will mitigate the impact of tariff fluctuations and logistical disruptions, while strategic inventory management will buffer against unforeseen delays. Second, investing in modular automation platforms and digital process analytics can accelerate method development, reduce manual error rates, and enable real-time monitoring of critical culture parameters.

Third, prioritizing the transition to serum-free and chemically defined media formulations will support regulatory compliance and enhance batch-to-batch consistency, particularly for clinical applications. Fourth, exploring three-dimensional culture systems and continuous perfusion technologies can unlock efficiency gains and foster more physiologically relevant biological models. Fifth, forging collaborative partnerships with contract research and manufacturing organizations can provide scalable capacity and specialized applications expertise, allowing organizations to focus internal resources on core competency areas.

By integrating these strategies into a cohesive roadmap-aligned with organizational objectives and market opportunities-industry leaders will be better positioned to capture value, maintain flexibility, and drive sustainable growth in the rapidly evolving cell culture landscape.

Detailing Robust Research Methodologies and Analytical Frameworks Employed to Ensure Accuracy and Rigor in Cell Culture Industry Insights

This analysis is grounded in a rigorous research methodology that combines primary interviews, secondary data validation, and advanced analytical frameworks. A series of in-depth discussions with senior executives, process engineers, and applications scientists provided firsthand perspectives on evolving customer requirements, technological adoption barriers, and strategic priorities. These qualitative inputs were triangulated with publicly available scientific literature, regulatory filings, and corporate disclosures to ensure comprehensive coverage of market dynamics.

Quantitative insights were derived from a structured database capturing product portfolios, patent filings, partnership announcements, and regional trade data. Statistical modeling techniques were employed to identify correlations between technology adoption trends and end-user investment patterns, while scenario analysis explored the potential ramifications of policy shifts and supply chain disruptions. Throughout this process, data integrity was maintained via cross-validation checks and peer reviews conducted by subject matter experts.

Finally, the research framework incorporates iterative feedback loops, allowing for continuous refinement of assumptions and ensuring that conclusions remain aligned with the latest industry developments. This multi-layered approach delivers a nuanced, fact-based understanding of the cell culture ecosystem, equipping stakeholders with the confidence to make informed strategic decisions.

Synthesizing Major Findings and Strategic Takeaways That Equip Stakeholders to Decode Trends and Capitalize on Opportunities Within the Cell Culture Space

The convergence of advanced media formulations, automated instrumentation, and data-driven workflows signals a pivotal inflection point in the cell culture sector. Key findings highlight the growing imperative for supply chain agility in response to tariff changes, the strategic value of segmentation to align product offerings with distinct user needs, and the importance of regional differentiation as biomanufacturing capabilities expand globally. Competitive profiling underscores a landscape in which both integrated life sciences firms and specialized niche players are investing heavily in R&D, partnerships, and digital solutions.

Moreover, actionable strategies such as diversifying supplier networks, adopting serum-free systems, and exploring continuous processing have emerged as critical levers for enhancing operational resilience. Together, these insights converge to form a cohesive strategic roadmap: one that emphasizes flexibility, collaboration, and technological integration as the foundations for future success.

In summation, stakeholders armed with this comprehensive analysis will be equipped to anticipate regulatory shifts, optimize resource allocation, and capitalize on emerging application frontiers, whether in therapeutic manufacturing, diagnostic testing, or basic research. The path forward will demand both agility and foresight, and those who embrace a data-informed, collaborative approach will be best positioned to thrive.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of artificial intelligence algorithms for enhanced cell culture monitoring and analysis
  • 5.2. Adoption of single-use bioreactor systems to streamline scalable mammalian cell culture manufacturing
  • 5.3. Development of serum-free and chemically defined media to improve reproducibility in cell culture
  • 5.4. Expansion of three-dimensional scaffold technologies for more physiologically relevant cell models
  • 5.5. Implementation of microfluidic organ-on-chip platforms to mimic human tissues in cell culture applications
  • 5.6. Application of CRISPR gene editing to optimize cell lines for increased productivity and stability
  • 5.7. Advancements in automated cell culture workflows through robotics and digital connectivity integration
  • 5.8. Shift towards sustainable and biodegradable consumables to reduce environmental impact in cell culture
  • 5.9. Biodegradable and sustainable consumables reduce environmental impact in large-scale cell culture operations
  • 5.10. Real-time metabolic flux analyzers integrated into cultures optimize nutrient feeding strategies

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Cell Culture Market, by Product Type

  • 8.1. Introduction
  • 8.2. Consumables
    • 8.2.1. Media
      • 8.2.1.1. Classical Media & Salts
      • 8.2.1.2. Serum-Free Media
      • 8.2.1.3. Specialty Media
    • 8.2.2. Reagents
      • 8.2.2.1. Antibiotics/Antimycotics
      • 8.2.2.2. Attachment & Matrix Factors
    • 8.2.3. Sera
      • 8.2.3.1. Fetal Bovine Serum
      • 8.2.3.2. Human Serum
  • 8.3. Instruments
    • 8.3.1. Bioreactors
    • 8.3.2. Centrifuges
    • 8.3.3. Cryostorage Systems
    • 8.3.4. Incubators

9. Cell Culture Market, by Cell Type

  • 9.1. Introduction
  • 9.2. Insect Cells
  • 9.3. Mammalian Cells
  • 9.4. Microbial Cells
  • 9.5. Plant Cells
  • 9.6. Stem Cells

10. Cell Culture Market, by Technique

  • 10.1. Introduction
  • 10.2. 2D Culture
  • 10.3. 3D Culture
  • 10.4. Perfusion Culture
  • 10.5. Suspension Culture

11. Cell Culture Market, by Application

  • 11.1. Introduction
  • 11.2. Biopharmaceutical Manufacturing
    • 11.2.1. Monoclonal Antibody Production
    • 11.2.2. Vaccine Production
  • 11.3. Cell Banking & Storage
    • 11.3.1. Cryopreservation
    • 11.3.2. Storage Services
  • 11.4. Clinical Diagnostics
    • 11.4.1. Immunodiagnostics
    • 11.4.2. Molecular Diagnostics
  • 11.5. Research & Development
    • 11.5.1. Drug Discovery
    • 11.5.2. Genetic Engineering
    • 11.5.3. Toxicology

12. Cell Culture Market, by End User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Biotechnology Companies
  • 12.4. Contract Research Organizations
  • 12.5. Hospitals & Diagnostic Labs
  • 12.6. Pharmaceutical Companies

13. Americas Cell Culture Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Cell Culture Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Cell Culture Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. CellGenix GmbH
    • 16.3.2. Corning Incorporated
    • 16.3.3. Danaher Corporation
    • 16.3.4. Emulate, Inc.
    • 16.3.5. Eppendorf AG
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Hi-Media Laboratories
    • 16.3.8. InSphero AG
    • 16.3.9. Invivogen
    • 16.3.10. Lonza Group
    • 16.3.11. Merck & Co., Inc.
    • 16.3.12. Miltenyi Biotec
    • 16.3.13. PromoCell GmbH
    • 16.3.14. Sartorius AG
    • 16.3.15. Synthecon, Incorporated
    • 16.3.16. Thermo Fisher Scientific Inc.
    • 16.3.17. VWR International, LLC by Avantor, Inc.
    • 16.3.18. Adolf Kuhner AG
    • 16.3.19. Advancion Corporation
    • 16.3.20. BioSpherix Ltd.
    • 16.3.21. Becton, Dickinson and Company
    • 16.3.22. Getinge AB
    • 16.3.23. Agilent Technologies, Inc.
    • 16.3.24. Bio-Techne Corporation
    • 16.3.25. STEMCELL Technologies Canada Inc.
    • 16.3.26. Solida Biotech GmBH
    • 16.3.27. Caisson Labs Inc.
    • 16.3.28. PAN-Biotech GmbH

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. CELL CULTURE MARKET: RESEARCHAI
  • FIGURE 26. CELL CULTURE MARKET: RESEARCHSTATISTICS
  • FIGURE 27. CELL CULTURE MARKET: RESEARCHCONTACTS
  • FIGURE 28. CELL CULTURE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY HUMAN SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY HUMAN SERUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY INCUBATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY PLANT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY PLANT CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY 2D CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY 2D CULTURE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY 3D CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY 3D CULTURE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL CELL CULTURE MARKET SIZE, BY PERFUSION CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL CULTURE MARKET SIZE, BY PERFUSION CULTURE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL CELL CULTURE MARKET SIZE, BY SUSPENSION CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL CULTURE MARKET SIZE, BY SUSPENSION CULTURE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL CELL CULTURE MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL CULTURE MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL CELL CULTURE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL CULTURE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL CELL CULTURE MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL CULTURE MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL CELL CULTURE MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL CULTURE MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL CELL CULTURE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL CULTURE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL CELL CULTURE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL CULTURE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL CELL CULTURE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL CULTURE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 183. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 186. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 187. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 188. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 189. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 191. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 193. CANADA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 195. CANADA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. CANADA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 214. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 215. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 216. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 217. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 218. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 219. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 220. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 221. MEXICO CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 222. MEXICO CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 223. MEXICO CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. MEXICO CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. MEXICO CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 227. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 243. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 244. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 245. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 246. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 247. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 248. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 249. BRAZIL CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 251. BRAZIL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. BRAZIL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 255. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 257. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 259. BRAZIL CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 267. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 270. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 271. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 272. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 273. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 274. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 275. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 276. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 277. ARGENTINA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 278. ARGENTINA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 279. ARGENTINA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ARGENTINA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. ARGENTINA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 282. ARGENTINA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 283. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 285. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 286. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 287. ARGENTINA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 288. ARGENTINA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 289. ARGENTINA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 290. ARGENTINA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 291. ARGENTINA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 292. ARGENTINA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 293. ARGENTINA CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. ARGENTINA CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY MEDIA, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY SERA, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY SERA, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 337. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
  • TABLE 345. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2025-2030 (USD MILLION)
  • TABLE 347. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 348. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 349. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 350. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 351. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 352. UNITED KINGDOM CELL CULTURE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 353. GERMANY CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. GERMANY CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 355. GERMANY CELL CULTURE MARKET SI